Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

Clinical trial NCT01481220 · COMPLETED

Trial details

NCT number: NCT01481220
Sponsor: Nordic MDS Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Thrombocytopenia

Start date: 2011-10-01
Primary completion: 2013-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.